#uspto-guidance

#uspto-guidance

AI is not a substitute for legal judgment, technical understanding, claim strategy, or client counseling. When implemented properly, AI is a force multiplier. It can compress timelines, improve consistency, reduce low-value friction, provide meaningful portfolio intelligence, and allow practitioners to spend more time on the work that actually requires professional expertise.

This week in Other Barks & Bites, IPWatchdog's IP news roundup: the House of Representatives passes drug patent legislation, while antitrust legislation targeting patent-related activities is introduced into the Senate and the Trump administration mandates pricing information for pharmaceutical ads; the Patent Trial and Appeal Board (PTAB) issues a pair of precedential decisions on cases with multiple petitions; the USPTO issues marijuana-related trademark guidelines and a notice on modifying patent term adjustment practices;